Birch Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$998K Sell
3,816
-129
-3% -$33.1K 0.47% 40
2026
Q2
$993K Buy
3,945
+106
+3% +$22.8K 0.51% 45
2026
Q1
$835K Buy
3,839
+82
+2% +$18.2K 0.49% 46
2025
Q4
$858K Sell
3,757
-15
-0.4% -$3.42K 0.49% 46
2025
Q3
$873K Buy
3,772
+1,419
+60% +$289K 0.51% 46
2025
Q2
$437K Buy
2,353
+265
+13% +$49.2K 0.35% 67
2025
Q1
$438K Buy
2,088
+594
+40% +$115K 0.39% 57
2024
Q4
$265K Buy
+1,494
New +$275K 0.3% 73

Other funds holding ABBV

Birch Financial Group's ABBV Position: Q3 2026 in Review

Birch Financial Group reduced its AbbVie (ABBV) stake by 3.3% in Q3 2026, selling an estimated $33.1K and leaving 3,816 shares worth $998K. The position accounts for 0.47% of the portfolio, ranked #40.

Birch Financial Group first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Birch Financial Group held 3,816 shares of AbbVie worth $998K as of Q3 2026.
  • Birch Financial Group sold 129 AbbVie shares in Q3 2026, an estimated $33.1K.
  • AbbVie made up 0.47% of Birch Financial Group's portfolio in Q3 2026, its #40 holding.
  • Birch Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Birch Financial Group's 13F filing for Q3 2026, filed 27 Oct 2026.